The effects of nicotine on locomotor activity and dopamine overflow in the alcohol-preferring AA and alcohol-avoiding ANA rats. 2000

K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
Department of Mental Health and Alcohol Research, National Public Health Institute, POB 719, 00101, Helsinki, Finland. kalervo.kiianmaa@ktl.fi

The aim of the study was to investigate the importance of the interaction between central dopaminergic and cholinergic mechanisms for ethanol reinforcement. This was done by comparing the effects of nicotine on locomotor activity and release of dopamine in the nucleus accumbens of the alcohol-preferring Alko Alcohol (AA) and alcohol-avoiding alko non-alcohol (ANA) rats. Nicotine was administered acutely (0.25, 0.50 or 0.75 mg/kg, s.c.) or repeatedly once daily (0.5 mg/kg, s.c.) for 8 days. An acute dose of nicotine increased locomotor activity and the extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), and homovanillic acid (HVA) measured with in vivo microdialysis suggesting stimulation of dopamine release by nicotine. No difference in the stimulation of locomotor activity or in the increase in the extracellular concentrations of dopamine or its metabolites by nicotine was found between the rat lines. The concentrations of nicotine in the plasma were also identical. The rats treated repeatedly with nicotine showed a progressive increase in locomotion. On the challenge day, 1 week after termination of nicotine or saline injections, rats previously treated with nicotine were activated more by nicotine than saline-treated rats. This behavioral sensitization was not accompanied by an increase in the amplitude of the neurochemical response to nicotine, but the duration of the increase in the levels of DOPAC was longer in the nicotine than saline-treated animals. The increases in locomotor activity and metabolite levels were, however, similar in both rat lines. These data suggest that differences in the interaction of central dopaminergic and cholinergic mechanisms probably do not contribute to the difference in ethanol self-administration between the AA and ANA rat lines.

UI MeSH Term Description Entries
D008297 Male Males
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009538 Nicotine Nicotine is highly toxic alkaloid. It is the prototypical agonist at nicotinic cholinergic receptors where it dramatically stimulates neurons and ultimately blocks synaptic transmission. Nicotine is also important medically because of its presence in tobacco smoke. Nicotine Bitartrate,Nicotine Tartrate
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D000428 Alcohol Drinking Behaviors associated with the ingesting of ALCOHOLIC BEVERAGES, including social drinking. Alcohol Consumption,Alcohol Intake,Drinking, Alcohol,Alcohol Drinking Habits,Alcohol Drinking Habit,Alcohol Intakes,Consumption, Alcohol,Drinking Habit, Alcohol,Habit, Alcohol Drinking,Habits, Alcohol Drinking,Intake, Alcohol
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D018722 Nicotinic Agonists Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. Cholinergic Agonists, Nicotinic,Cholinergic Agonist, Nicotinic,Nicotinic Agonist,Agonist, Nicotinic,Agonist, Nicotinic Cholinergic,Agonists, Nicotinic,Agonists, Nicotinic Cholinergic,Nicotinic Cholinergic Agonist,Nicotinic Cholinergic Agonists

Related Publications

K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
February 2001, Naunyn-Schmiedeberg's archives of pharmacology,
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
January 1999, Alcohol (Fayetteville, N.Y.),
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
February 2009, Alcoholism, clinical and experimental research,
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
May 1999, Alcohol (Fayetteville, N.Y.),
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
September 1995, Pharmacology, biochemistry, and behavior,
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
January 2001, Alcohol and alcoholism (Oxford, Oxfordshire),
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
January 2010, Alcohol and alcoholism (Oxford, Oxfordshire),
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
January 1991, Alcohol (Fayetteville, N.Y.),
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
September 2006, Addiction biology,
K Kiianmaa, and P Tuomainen, and N Makova, and T Seppä, and J A Mikkola, and T Petteri Piepponen, and L Ahtee, and P Hyytiä
January 2015, Frontiers in psychiatry,
Copied contents to your clipboard!